The role of thalidomide in the management of erythema nodosum leprosum

Erythema nodosum leprosum (ENL, Type 2 reactions) complicates lepromatous and borderline lepromatous leprosy and can affect many organ systems, often with irreversible damage. The reactions commonly occur in the 2 years after starting treatment and often run a recurrent or chronic course, sometimes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leprosy review 2007-09, Vol.78 (3), p.197-215
Hauptverfasser:	WALKER, Steven L, WATERS, Michael F. R, LOCKWOOD, Diana N. J
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspirin - administration & dosage Aspirin - therapeutic use Bacterial diseases Biological and medical sciences Care and treatment Clofazimine Controlled Clinical Trials as Topic Corticosteroids Decision Trees Dermatology Diagnosis Dosage and administration Drug therapy Erythema nodosum Erythema Nodosum - drug therapy Erythema Nodosum - pathology General aspects Human bacterial diseases Humans Infectious diseases Leprostatic Agents - administration & dosage Leprostatic Agents - adverse effects Leprostatic Agents - therapeutic use Leprosy Medical sciences Pentoxifylline - administration & dosage Pentoxifylline - therapeutic use Prednisolone Risk factors Thalidomide Thalidomide - administration & dosage Thalidomide - adverse effects Thalidomide - therapeutic use Tropical bacterial diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!